U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07046832) titled 'Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy' on June 13.
Brief Summary: This clinical feasibility evaluation is intended to further characterize and quantify the potential benefits of the FDA-cleared XR90 Augmented Reality (AR )imaging and guidance platform utilization in percutaneous soft tissue biopsy. This study will seek to build on the findings of safety, procedural benefits, and overall clinical feasibility shown in previous bench, cadaveric, and single-site clinical evaluations.
Study Start Date: June 27
Study Type: INTERVENTIONAL
Condition:
Oncology
Intervent...